3D Systems 配当と自社株買い
配当金 基準チェック /06
3D Systems配当金を支払った記録がありません。
主要情報
n/a
配当利回り
4.3%
バイバック利回り
| 総株主利回り | 4.3% |
| 将来の配当利回り | n/a |
| 配当成長 | n/a |
| 次回配当支払日 | n/a |
| 配当落ち日 | n/a |
| 一株当たり配当金 | n/a |
| 配当性向 | n/a |
最近の配当と自社株買いの更新
Recent updates
DDD: Dental Solutions And Factory Software Will Support Future Earnings Power
Analysts have slightly lowered their price target on 3D Systems to $5.00, citing modest adjustments to the discount rate, revenue growth, profit margin expectations, and assumed future P/E. Together, these factors point to a more cautious but still constructive view on the stock's valuation.3D Systems: Aerospace And Defense Narrative Isn't Compelling
Summary 3D Systems faces persistent headwinds from dental market weakness and soft capital spending, although this is now being offset by strength in aerospace, defense, and personalized healthcare. DDD expects solid aerospace and defense revenue growth in 2026, but this appears insufficient to create a topline growth acceleration. Cost-cutting efforts are paying off, leading to improved margins, but 3D Systems remains a long way from GAAP profitability. While 3D Systems' valuation is modest, this reflects the company's weak fundamentals rather than mispricing. Read the full article on Seeking AlphaDDD: New CFO And Industrial Expansion Will Support Future Earnings Power
Analysts have made a slight adjustment to their price target on 3D Systems, reflecting updated assumptions about the discount rate, revenue growth, profit margins, and future P/E. This has led to a modest recalibration of fair value, with their target remaining close to $5.00 per share.DDD: New CFO And Dental Expansion Will Support Future Earnings Power
Analysts have maintained their price target for 3D Systems at $5.00, reflecting only minor adjustments to assumptions related to discount rate, revenue growth, profit margin, and future P/E, which together support an unchanged valuation view. What's in the News Phyllis Nordstrom is set to become Chief Financial Officer on March 23, 2026, after serving as Interim CFO since August 2025, while continuing as Chief Administrative Officer reporting to President and CEO Dr. Jeffrey Graves (Key Developments).DDD: Dental Solutions Expansion And New CFO Will Support Future Earnings Power
Analysts now set a higher price target of $5.00 for 3D Systems, up from $4.75, citing updated assumptions for revenue growth, profit margins, a lower discount rate, and a higher future P/E multiple. What's in the News Phyllis Nordstrom is appointed Chief Financial Officer, effective March 23, 2026, after serving as Interim CFO since August 2025.DDD: Expanded Med Tech Indications And Digital Dentures Will Support Margin Upside
Analysts have slightly trimmed their price target on 3D Systems to $3.63, reflecting small tweaks to assumptions around discount rate, profit margin and future P/E, while keeping their fair value view broadly in line. What's in the News 3D Systems introduced three new NextDentJet Base shades for its NextDent Jetted Denture Solution, adding Dark Pink, Light Pink, and Red Pink to the existing Light Tone option to better match a range of natural gum tones.DDD: Expanded Dental And Orthopedic Applications Will Support Higher Margin Confidence
Analysts have maintained their $3.63 fair value estimate for 3D Systems, with only minor adjustments to inputs, including a slightly higher discount rate and modestly lower profit margin assumptions, shaping this latest price target update. What's in the News 3D Systems introduced three new NextDentJet Base shades: Dark Pink, Light Pink, and Red Pink, expanding its NextDent Jetted Denture Solution to four base shades aimed at better matching a wider range of natural gum tones across patient populations.DDD: Expanded Med Tech Indications Will Support Higher Margin Confidence
Analysts have adjusted their price targets on 3D Systems slightly, with modest tweaks to the discount rate, profit margin expectations, and forward P/E assumptions, leading to a refined view of fair value for the shares. What's in the News FDA granted 510(k) clearance expanding indications for 3D Systems' VSP Orthopedics platform to include skeletally mature adolescents of normal bone stature, moving prior off label use for these patients into standard, reimbursable procedures at leading centers (Key Developments).DDD: Margin Execution And Med Tech Expansion Will Support Higher Confidence
Analysts have raised their price target on 3D Systems to US$4.75 from US$4.00. This reflects updated views on the company's margin outlook and valuation multiples.DDD: Expanded Med Tech Margins And Execution Will Support Greater Market Confidence
Analysts lifted their price target on 3D Systems to $4.75 from $4.00, reflecting updated assumptions around discount rates, profit margins and future P/E multiples that influence their valuation outlook. Analyst Commentary Recent research reflects a modestly more constructive stance on 3D Systems, with the updated US$4.75 price target framing how some on the Street view the balance of risk and reward.There's No Escaping 3D Systems Corporation's (NYSE:DDD) Muted Revenues Despite A 45% Share Price Rise
3D Systems Corporation ( NYSE:DDD ) shareholders are no doubt pleased to see that the share price has bounced 45% in...DDD: Med Tech And Industrial Demand Will Drive Improved Earnings Power
Analysts have raised their price target on 3D Systems to $4.75 from $4.00, reflecting improved expectations for a return to revenue growth and a slightly higher assumed future earnings multiple, despite a modestly higher discount rate. Analyst Commentary Bullish analysts highlight that the new price target reflects growing confidence in 3D Systems’ ability to stabilize its core business and return to sustainable top line expansion.DDD: Execution On New Products And Cost Discipline Will Drive Confidence
Analysts have modestly increased their price target for 3D Systems to $4.75 from $4.00, citing a slightly higher assumed future earnings multiple and a marginally higher discount rate while leaving long term growth and margin expectations effectively unchanged. Analyst Commentary Analysts view the modest price target increase as a reflection of slightly improved confidence in 3D Systems' ability to execute on its strategy, while still recognizing meaningful execution and market risks at current levels.DDD: Margin Stability And Cost Discipline Will Drive Confidence In 2025
Analysts have raised their price target on 3D Systems from $4.00 to $4.75, citing shifts in projected discount rates and modest adjustments to revenue growth expectations as core reasons for their updated outlook. Analyst Commentary Analyst sentiment on 3D Systems has shifted following recent developments, prompting a closer examination of both the company’s growth potential and the associated risks.3D Systems' (NYSE:DDD) Profits Appear To Have Quality Issues
The stock price didn't jump after 3D Systems Corporation ( NYSE:DDD ) posted decent earnings last week. We did some...DDD: Margin Strength And New Contract Will Drive Outperformance Ahead
Analysts have increased their price target for 3D Systems from $3.25 to $3.63. They cite improved revenue growth and a significant strengthening of profit margins as key factors driving the outlook higher.Benign Growth For 3D Systems Corporation (NYSE:DDD) Underpins Stock's 31% Plummet
The 3D Systems Corporation ( NYSE:DDD ) share price has softened a substantial 31% over the previous 30 days, handing...3D Systems Corporation (NYSE:DDD) Shares Fly 34% But Investors Aren't Buying For Growth
Despite an already strong run, 3D Systems Corporation ( NYSE:DDD ) shares have been powering on, with a gain of 34% in...Healthcare Customization And Additive Manufacturing Will Forge A Resilient Future
As 3D Systems’ net profit margin and revenue growth forecasts remain unchanged at 0.72% and -4.5% respectively, the analyst consensus price target is also maintained at $3.25. What's in the News 3D Systems launched the NextDent Jetted Denture Solution and NextDent 300 MultiJet printer in the U.S., enabling rapid, post-cure-free, single-piece, dual-material dentures with improved aesthetics and durability.3D Systems: Restructuring And The Challenging Path To Turnaround
Summary 3D Systems face revenue decline and margin pressures due to manufacturing sector weakness and high-interest rates, leading to a -10.5% revenue CAGR from FY21 to FY24. Management's restructuring plan includes a $50 million cost-cutting program and the sale of Geomagic software, but breakeven requires significant revenue growth and an industry rebound. Comparison with Stratasys and Nano Dimension shows 3D Systems' underperformance in revenue, margins, and debt, with a steep stock price decline of 86.42% since January 2022. Despite restructuring efforts, high competition and past acquisition strategy raise doubts about achieving profitability, leading to a "hold" rating for 3D Systems. Read the full article on Seeking AlphaRegenerative Medicine And Dental Focus Will Open New Markets
Collaborations in regenerative medicine and dental market focus position 3D Systems for potential future revenue growth.A Piece Of The Puzzle Missing From 3D Systems Corporation's (NYSE:DDD) 39% Share Price Climb
Despite an already strong run, 3D Systems Corporation ( NYSE:DDD ) shares have been powering on, with a gain of 39% in...3D Systems: A Strong One For Speculative Investors
Summary 3D Systems is a leader in 3D printing with diverse technologies, excelling in medical, aerospace, and automotive sectors, despite financial challenges. The company is investing in bioprinting and custom implants, with valuable partnerships in defense and aerospace, driving future growth. Revenue is expected to decline in 2024 due to macroeconomic conditions, but operational efficiency and new product launches show promise. Investors with high-risk tolerance may consider 3D Systems for speculative growth, while conservative investors should wait for stable profitability. Read the full article on Seeking Alpha3D Systems: Waiting For More Clarity On The Profitability Path
Summary 3D Systems is a world leader in 3D printing and offers a complete portfolio of metal and plastic materials. It enjoys a solid positioning in the healthcare segment (dental, prosthesis, and regenerative medicine). As the sector makes losses and consolidates, the firm could reinforce its positioning. The balance sheet is tight, and a clear path toward profitability remains to be determined. While the stock is undervalued, a rerating seems unlikely unless I can refinance its 2026 obligation or become rapidly cash flow positive. I rate the stock as a HOLD. Read the full article on Seeking Alpha3D Systems: Green Shoots Amidst Ongoing Macro Challenges
Summary 3D Systems reported weak results in Q1 but returned to sequential growth in the second quarter and now appears to be more optimistic about its near-term prospects. 3D Systems expects to be profitable on an adjusted EBITDA basis in the fourth quarter on the back of revenue growth and cost-cutting efforts. 3D Systems' valuation is now fairly modest, which could result in solid returns if the company can meet its guidance. Industry dynamics remain tough, though, and I continue to think that there are better ways to capitalize on additive manufacturing than hardware companies. Read the full article on Seeking Alpha3D Systems: Don't Print Your Hopes Up At The 52-Week Low
Summary 3D Systems Corp has faced a challenging industry backdrop with declining sales for key additive manufacturing markets. The company has yet to file its 2023 annual report. We expect shares to remain under pressure. Read the full article on Seeking AlphaAnalyst Estimates: Here's What Brokers Think Of 3D Systems Corporation (NYSE:DDD) After Its Yearly Report
3D Systems Corporation ( NYSE:DDD ) missed earnings with its latest yearly results, disappointing overly-optimistic...3D Systems: Another Difficult Year Ahead
Summary 3D Systems reported soft Q4 2023 results, with printer sales and dental orthodontics areas of particular weakness. Competition from China and customer concentration in the dental business pose challenges for 3D Systems. The company is implementing cost-cutting initiatives and focusing on regenerative medicine to stem losses and drive growth. DDD's valuation remains relatively high given the challenges facing the company and its lack of differentiation. Read the full article on Seeking Alpha決済の安定と成長
配当データの取得
安定した配当: DDDの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。
増加する配当: DDDの配当金が増加しているかどうかを判断するにはデータが不十分です。
配当利回り対市場
| 3D Systems 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (DDD) | n/a |
| 市場下位25% (US) | 1.4% |
| 市場トップ25% (US) | 4.2% |
| 業界平均 (Machinery) | 1.1% |
| アナリスト予想 (DDD) (最長3年) | n/a |
注目すべき配当: DDDは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。
高配当: DDDは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。
株主への利益配当
収益カバレッジ: DDDの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。
株主配当金
キャッシュフローカバレッジ: DDDが配当金を報告していないため、配当金の持続可能性を計算できません。
高配当企業の発掘
企業分析と財務データの現状
| データ | 最終更新日(UTC時間) |
|---|---|
| 企業分析 | 2026/05/07 13:04 |
| 終値 | 2026/05/07 00:00 |
| 収益 | 2025/12/31 |
| 年間収益 | 2025/12/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
3D Systems Corporation 4 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。26
| アナリスト | 機関 |
|---|---|
| Benjamin Reitzes | Barclays |
| Kenneth Vallace | Berenberg |
| Wamsi Mohan | BofA Global Research |